Page 7 - Rapid Diagnostics News Today

/PRNewswire/ -- Abbott (NYSE: ABT) today announced financial results for the first quarter ended March 31, 2023. First-quarter GAAP diluted EPS of $0.75 and...

/PRNewswire/ -- The "Cardiac Troponin Diagnostics - Forecasts and Opportunities to 2025" report has been added to ResearchAndMarkets.coms offering. Cardiac...

/PRNewswire/ -- The "Global Rapid Diagnostics Market 2021-2031 by Product, Prescription, Platform, Application, End User, and Region: Trend Forecast and Growth...

/PRNewswire/ -- The "Global Rapid Diagnostics Market 2021-2031 by Product, Prescription, Platform, Application, End User, and Region: Trend Forecast and Growth...

/PRNewswire/ -- The "Global Monkeypox Diagnostics Market by Assay, Country, Product, and Place, with Executive & Consultant Guides and Market Analysis &...

/PRNewswire/ -- The "Global Monkeypox Diagnostics Market by Assay, Country, Product, and Place, with Executive & Consultant Guides and Market Analysis &...

Dublin, Dec. 21, 2022 (GLOBE NEWSWIRE) -- The "Cardiac Troponin Diagnostics - Forecasts and Opportunities to 2025" report has been added to ...

CHICAGO, Dec. 8, 2022 /PRNewswire/ -- Point of Care/ Rapid Diagnostics Market is expected to reach USD 75.5 billion by 2027 from an estimated USD 45.4 billion in 2022, at a CAGR of 10.7% from

Rapid Test Cards Market OverviewRapid test card is a medical diagnostic test card that qualitatively detects the presence of pathogens in a sample (blood/serum). Rapid test cards are widely used in clinical settings as they offer quick results. Quick tests are utilized as a part of an assortment of purpose of care-s...

4th generation testing, equipped with high sensitivity and specificity, detects more acute infections, which account for 5 to 20 per cent of all HIV infections